Bio Pharmaceutical firm with new drug platform, 15 drugs in the pipeline and $9million in public grants to date, seeking $10mm for FDA tests
Only investors on Gust who have been granted access can view this content.
Interested in this startup? Sign In or Sign Up to request more information.
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.
Get Started for Free